CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-12 | Swisher Daniel N JR Director | Sale 10b5-1 | −1,800 | $72.17 | $130K | 400 |
| 2025-05-12 | Swisher Daniel N JR Director | Sale 10b5-1 | −400 | $71.55 | $29K | 0 |
| 2025-05-12 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −1,800 | 0 | ||
| 2025-05-12 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −400 | 12,100 | ||
| 2025-05-06 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +7,060 | $21.65 | $153K | 12,547 |
| 2025-05-06 | Guyer William Chief Development Officer | Sale 10b5-1 | −7,060 | $74.31 | $525K | 5,487 |
| 2025-05-06 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −7,060 | 442,262 | ||
| 2025-05-02 | Maduck Sean See Remarks | Option exercise 10b5-1 | +26,554 | $5.05 | $134K | 112,176 |
| 2025-05-02 | Maduck Sean See Remarks | Sale 10b5-1 | −25,847 | $72.21 | $1.9M | 86,329 |
| 2025-05-02 | Maduck Sean See Remarks | Sale 10b5-1 | −707 | $72.98 | $52K | 85,622 |
| 2025-05-02 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −26,554 | 81,986 | ||
| 2025-05-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −18,480 | $72.52 | $1.3M | 2,963,505 |
| 2025-05-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −21,520 | $73.22 | $1.6M | 2,941,985 |
| 2025-05-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +12,856 | $5.05 | $65K | 98,478 |
| 2025-05-01 | Maduck Sean See Remarks | Sale 10b5-1 | −12,856 | $71.94 | $925K | 85,622 |
| 2025-05-01 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −12,856 | 108,540 | ||
| 2025-05-01 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +9,350 | $13.56 | $127K | 18,359 |
| 2025-05-01 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −9,350 | $71.96 | $673K | 9,009 |
| 2025-05-01 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −9,350 | 46,571 | ||
| 2025-04-10 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $12.13 | $27K | 2,200 |
Page 27 of 61 · 1,220 trades